Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 551 to 600 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBC1 DOMAIN FAMILY PROTEIN C22ORF4. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.046789\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.172653\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.271000214\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBC1D22A\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEAR RECEPTOR COACTIVATOR 7; ESTROGEN RECEPTOR ASSOCIATED PROTEIN 140 KDA. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
NCOA7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"LATS, LARGE TUMOR SUPPRESSOR, HOMOLOG 2; LATS (LARGE TUMOR SUPPRESSOR, DROSOPHILA) HOMOLOG 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0385424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.142223\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270999768\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LATS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH-LIKE PROTEIN 2 (FOVEA-ASSOCIATED SH3 DOMAIN BINDING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0368814\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.136094\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270999456\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DJ132F21.2 (CONTAINS A NOVEL PROTEIN SIMILAR TO THE L82E FROM DROSOPHILA) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0362497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.133763\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270999454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C20orf118\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH-LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0371738\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.137173\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270999395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SH3BGRL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OXIDATION RESISTANCE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0380979\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.140583\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270999338\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OXR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYMECLIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.50366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.85853\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270999123\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DYM\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBC1 DOMAIN FAMILY PROTEIN C22ORF4-LIKE (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0359807\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.132771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270998185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBC1D22B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAV-LIKE PROTEIN 3 (HU-ANTIGEN C) (HUC) (PARANEOPLASTIC CEREBELLAR DEGENERATION-ASSOCIATED ANTIGEN) (PARANEOPLASTIC LIMBIC ENCEPHALITIS ANTIGEN 21). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.539175\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.99055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270867348\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; UDP-GALNAC TRANSFERASE 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0483159\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.178411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270812338\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GALNT2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
562\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.06428\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.92996\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270811917\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RAD54L2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
563\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.230346\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.850576\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270811779\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BTBD9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO EXPRESSED SEQUENCE AI415388 (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0370824\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.136931\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270810846\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GALNTL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SERINE/THREONINE PROTEIN PHOSPHATASE 2A, 65 KDA REGULATORY SUBUNIT A, ALPHA ISOFORM (PP2A, SUBUNIT A, PR65-ALPHA ISOFORM) (PP2A, SUBUNIT A, R1-ALPHA ISOFORM) (MEDIUM TUMOR ANTIGEN-ASSOCIATED 61 KDA PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.1722\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.635895\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270799424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP2R1A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAV-LIKE PROTEIN 1 (HU-ANTIGEN R) (HUR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.449826\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.66144\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270744655\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ELAVL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.136702\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.504965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270715792\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DHRS7B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO KINASE SUPPRESSOR OF RAS (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0932883\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.344638\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270684893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KSR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (EC 2.7.1.-) (MAP KINASE KINASE 2) (MAPKK 2) (ERK ACTIVATOR KINASE 2) (MAPK/ERK KINASE 2) (MEK2). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.251342\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.928542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.270684579\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP2K2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (EC 2.7.1.-) (MAP KINASE KINASE 1) (MAPKK 1) (ERK ACTIVATOR KINASE 1) (MAPK/ERK KINASE 1) (MEK1). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MAP2K1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0726249\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.268301\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270684418\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KSR2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAV-LIKE PROTEIN 4 (PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGEN HUD) (HU-ANTIGEN D). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.495507\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.83073\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270660884\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ELAVL4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SERINE/THREONINE PROTEIN PHOSPHATASE 2A, 65 KDA REGULATORY SUBUNIT A, BETA ISOFORM (PP2A, SUBUNIT A, PR65-BETA ISOFORM) (PP2A, SUBUNIT A, R1-BETA ISOFORM). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.181797\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.671805\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270609775\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP2R1B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAV-LIKE PROTEIN 2 (HU-ANTIGEN B) (HUB) (ELAV-LIKE NEURONAL PROTEIN 1) (NERVOUS SYSTEM-SPECIFIC RNA BINDING PROTEIN HEL-N1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.495602\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.83168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270572371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ELAVL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BILE ACID COENZYME A: AMINO ACID N-ACYLTRANSFERASE; GLYCINE N-CHOLOYLTRANSFERASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.200205\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.740509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270361333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BAAT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL ACYL-COENZYME A THIOESTER HYDROLASE 2A (EC 3.1.2.2) (PEROXISOMAL LONG-CHAIN ACYL-COA THIOESTERASE 2) (ZAP128). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.230682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.853273\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270349583\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACOT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL ACYL-COA THIOESTERASE 2B; LIKELY ORTHOLOG OF MOUSE PEROXISOMAL ACYL-COA THIOESTERASE 2B. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.257341\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.951909\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270342018\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACOT4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
578\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.565201\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.09213\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270155774\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
IRF2BP2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
579\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.483254\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.78896\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270131249\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C14orf4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPATOCYTE NUCLEAR FACTOR 3-ALPHA (HNF-3A) (FORKHEAD BOX PROTEIN A1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.404388\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.49712\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270110612\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOXA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUITIN-LIKE PROTEIN SUMO-1 CONJUGATING ENZYME (EC 6.3.2.19) (SUMO- 1-PROTEIN LIGASE) (UBIQUITIN CARRIER PROTEIN) (UBIQUITIN-CONJUGATING ENZYME UBCE2A) (P18). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.334862\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.23982\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270089206\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UBE2I\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SERINE/THREONINE PROTEIN PHOSPHATASE 2A, 55 KDA REGULATORY SUBUNIT B, ALPHA ISOFORM (PP2A, SUBUNIT B, B-ALPHA ISOFORM) (PP2A, SUBUNIT B, B55-ALPHA ISOFORM) (PP2A, SUBUNIT B, PR55-ALPHA ISOFORM) (PP2A, SUBUNIT B, R2-ALPHA ISOFORM). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0948257\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.351165\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270031751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UNCHARACTERIZED HEMATOPOIETIC STEM/PROGENITOR CELLS PROTEIN MDS026. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0951162\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.352242\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270030831\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP2R2D\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SERINE/THREONINE PROTEIN PHOSPHATASE 2A, 55 KDA REGULATORY SUBUNIT B, BETA ISOFORM (PP2A, SUBUNIT B, B-BETA ISOFORM) (PP2A, SUBUNIT B, B55- BETA ISOFORM) (PP2A, SUBUNIT B, PR55-BETA ISOFORM) (PP2A, SUBUNIT B, R2-BETA ISOFORM). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0961987\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.356254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270028407\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP2R2B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SERINE/THREONINE PROTEIN PHOSPHATASE 2A, 55 KDA REGULATORY SUBUNIT B, GAMMA ISOFORM (PP2A, SUBUNIT B, B-GAMMA ISOFORM) (PP2A, SUBUNIT B, B55-GAMMA ISOFORM) (PP2A, SUBUNIT B, PR55-GAMMA ISOFORM) (PP2A, SUBUNIT B, R2-GAMMA ISOFORM) (IMYPNO1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.101295\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.375141\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270018473\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP2R2C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-2 (ACTIVATING TRANSCRIPTION FACTOR 2) (CAMP RESPONSE ELEMENT BINDING PROTEIN CRE- BP1) (HB16). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.673422\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.49889\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269488453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATF2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-7 (ACTIVATING TRANSCRIPTION FACTOR 7) (TRANSCRIPTION FACTOR ATF-A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.574984\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.13394\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269447126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATF7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S8. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122515\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.454799\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269382738\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.393043\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.45917\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269360664\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGM2L1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-METHYLTHIOADENOSINE PHOSPHORYLASE (EC 2.4.2.28) (MTA PHOSPHORYLASE) (MTAPASE). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.12174\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.452001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.269335687\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTAP\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 1 (EC 2.1.1.-) (RRNA (URIDINE-2'-O-)-METHYLTRANSFERASE) (JM23 PROTEIN). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FTSJ1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SPECTRIN BETA CHAIN, BRAIN 2 (SPECTRIN, NON-ERYTHROID BETA CHAIN 2) (BETA-III SPECTRIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0341846\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.126926\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269327009\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SPTBN2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.460943\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.71147\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269325784\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGM2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHOACETYLGLUCOSAMINE MUTASE (EC 5.4.2.3) (PAGM) (ACETYLGLUCOSAMINE PHOSPHOMUTASE) (N-ACETYLGLUCOSAMINE-PHOSPHATE MUTASE) (PHOSPHOGLUCOMUTASE 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.537765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.99671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269325541\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGM3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SPECTRIN BETA CHAIN, BRAIN 1 (SPECTRIN, NON-ERYTHROID BETA CHAIN 1) (BETA-II SPECTRIN) (FODRIN BETA CHAIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0426374\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.158312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26932513\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SPTBN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPATOCYTE NUCLEAR FACTOR 3-BETA (HNF-3B) (FORKHEAD BOX PROTEIN A2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.414022\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.53743\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269294862\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOXA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM DOMAIN ONLY 7; ZINC-FINGER DOMAIN-CONTAINING PROTEIN; LOMP PROTEIN; F-BOX ONLY PROTEIN 20; F-BOX PROTEIN FBX20. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.126132\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.468539\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269202777\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LMO7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CAMP RESPONSE ELEMENT-BINDING PROTEIN CRE-BPA. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.132014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.490424\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2691834\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CREB5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN ZIC 2 (ZINC FINGER PROTEIN OF THE CEREBELLUM 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.307359\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.14212\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269112703\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZIC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN ZIC 3 (ZINC FINGER PROTEIN OF THE CEREBELLUM 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.25098\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.932647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269105031\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZIC3\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/